Atypical pituitary adenomas: Incidence, clinical characteristics, and implications

Journal of Neurosurgery

Volumn 114, Issue 2, 2011, Pages 336-344

  Zada, Gabriel ^a   Woodmansee, Whitney W ^a   Ramkissoon, Shakti ^a   Amadio, Jordan ^a   Nose, Vania ^a   Laws Jr , Edward R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Atypical; Carcinoma; Ki 67; MIB 1; p53; Pituitary adenoma; Transsphenoidal; Tumor biology

Indexed keywords

CORTICOTROPIN; FOLLITROPIN; KI 67 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CORRELATION ANALYSIS; CUSHING DISEASE; FEMALE; FOLLOW UP; GROWTH HORMONE SECRETING ADENOMA; HISTOPATHOLOGY; HUMAN; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METASTASIS; MITOSIS RATE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NULL CELL ADENOMA; PRIORITY JOURNAL; PROLACTINOMA; STAINING; TRANSSPHENOIDAL SURGERY; TUMOR RECURRENCE; WORLD HEALTH ORGANIZATION;

ADENOMA; ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; KI-67 ANTIGEN; MALE; MIDDLE AGED; PITUITARY GLAND; PITUITARY NEOPLASMS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 79551711233     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2010.8.JNS10290     Document Type: Article

References (37)

1. DeLellis R, Lloyd RV, Heitz P, Eng C (eds): World Health Organization Classification of Tumours: Tumours of Endocrine Organs. Lyon: IARC Press, 2004
2. Figarella-Branger D, Trouillas J: The new WHO classification of human pituitary tumors: comments. Acta Neuropathol 111:71-72, 2006 (Pubitemid 43013834)
3. Filippella M, Galland F, Kujas M, Young J, Faggiano A, Lombardi G, et al: Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study. Clin Endocrinol (Oxf) 65:536-543, 2006 (Pubitemid 44414280)
4. Fusco A, Zatelli MC, Bianchi A, Cimino V, Tilaro L, Veltri F, et al: Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas. J Clin Endocrinol Metab 93:2746-2750, 2008 (Pubitemid 352008545)
5. Gejman R, Swearingen B, Hedley-Whyte ET: Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas. Hum Pathol 39:758-766, 2008 (Pubitemid 351601606)
6. Grossman AB: The 2004 World Health Organization classification of pituitary tumors: is it clinically helpful? Acta Neuropathol 111:76-77, 2006
7. Hentschel SJ, McCutcheon E, Moore W, Durity FA: P53 and MIB-1 immunohistochemistry as predictors of the clinical behavior of nonfunctioning pituitary adenomas. Can J Neurol Sci 30:215-219, 2003 (Pubitemid 37064515)
8. Honegger J, Prettin C, Feuerhake F, Petrick M, Schulte-Mönting J, Reincke M: Expression of Ki-67 antigen in nonfunctioning pituitary adenomas: correlation with growth velocity and invasiveness. J Neurosurg 99:674-679, 2003 (Pubitemid 37159044)
9. Jaffrain-Rea ML, Di Stefano D, Minniti G, Esposito V, Bultrini A, Ferretti E, et al: A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumours: secreting versus non-secreting adenomas. Endocr Relat Cancer 9:103-113, 2002 (Pubitemid 34832163)
10. Kleinschmidt-DeMasters BK: Subtyping does matter in pituitary adenomas. Acta Neuropathol 111:84-85, 2006
11. Knosp E, Kitz K, Perneczky A: Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67. Neurosurgery 25:927-930, 1989 (Pubitemid 20073386)
12. Knosp E, Steiner E, Kitz K, Matula C: Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610-618, 1993 (Pubitemid 23292752)
13. Kontogeorgos G: Innovations and controversies in the WHO classification of pituitary adenomas. Acta Neuropathol 111:73-75, 2006
14. Kontogeorgos G: Predictive markers of pituitary adenoma behavior. Neuroendocrinology 83:179-188, 2006
15. Kovacs K: The 2004 WHO classification of pituitary tumors: comments. Acta Neuropathol 111:62-63, 2006
16. Kovacs K, Horvath E, Coire C, Cusimano M, Smyth H, Scheithauer BW, et al: Pituitary corticotroph hyperplasia preceding adenoma in a patient with Nelson's syndrome. Clin Neuropathol 25:74-80, 2006
17. Laws ER Jr, Lopes MB: The new WHO classification of pituitary tumors: highlights and areas of controversy. Acta Neuropathol 111:80-81, 2006
18. Losa M, Franzin A, Mangili F, Terreni MR, Barzaghi R, Veglia F, et al: Proliferation index of nonfunctioning pituitary adenomas: correlations with clinical characteristics and long-term follow-up results. Neurosurgery 47:1313-1319, 2000
19. Marucci G, Faustini-Fustini M, Righi A, Pasquini E, Frank G, Agati R, et al: Thyrotropin-secreting pituitary tumours: significance of "atypical adenomas" in a series of 10 patients and association with Hashimoto thyroiditis as a cause of delay in diagnosis. J Clin Pathol 62:455-459, 2009
20. Mastronardi L, Guiducci A, Spera C, Puzzilli F, Liberati F, Maira G: Ki-67 labelling index and invasiveness among anterior pituitary adenomas: analysis of 103 cases using the MIB-1 monoclonal antibody. J Clin Pathol 52:107-111, 1999 (Pubitemid 29062344)
21. Mizoue T, Kawamoto H, Arita K, Kurisu K, Tominaga A, Uozumi T: MIB1 immunopositivity is associated with rapid regrowth of pituitary adenomas. Acta Neurochir (Wien) 139:426-432, 1997 (Pubitemid 27229189)
22. Ogawa Y, Ikeda H, Tominaga T: Clinicopathological study of prognostic factors in patients with pituitary adenomas and Ki-67 labeling index of more than 3%. J Endocrinol Invest 7:581-584, 2009
23. Oliveira MC, Marroni CP, Pizarro CB, Pereira-Lima JF, Barbosa-Coutinho LM, Ferreira NP: Expression of p53 protein in pituitary adenomas. Braz J Med Biol Res 35:561-565, 2002 (Pubitemid 34568224)
24. Paek KI, Kim SH, Song SH, Choi SW, Koh HS, Youm JY, et al: Clinical significance of Ki-67 labeling index in pituitary macroadenoma. J Korean Med Sci 20:489-494, 2005
25. Perry A, Scheithauer BW: Commentary: Classification and grading of pituitary tumors. Observations of two working neu ro pathologists. Acta Neuropathol 111:68-70, 2006 (Pubitemid 43013833)
26. Pizarro CB, Oliveira MC, Coutinho LB, Ferreira NP: Measurement of Ki-67 antigen in 159 pituitary adenomas using the MIB-1 monoclonal antibody. Braz J Med Biol Res 37:235-243, 2004 (Pubitemid 38268156)
27. Saeger W, Lüdecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S: Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 156:203-216, 2007 (Pubitemid 46554515)
28. Salehi F, Agur A, Scheithauer BW, Kovacs K, Lloyd RV, Cusimano M: Ki-67 in pituitary neoplasms: a review - part I. Neurosurgery 65:429-437, 2009
29. Scheithauer BW, Gaffey TA, Lloyd RV, Sebo TJ, Kovacs KT, Horvath E, et al: Pathobiology of pituitary adenomas and carcinomas. Neurosurgery 59:341-353, 2006 (Pubitemid 44325877)
30. Scheithauer BW, Jaap AJ, Horvath E, Kovacs K, Lloyd RV, Meyer FB, et al: Clinically silent corticotroph tumors of the pituitary gland. Neurosurgery 47:723-730, 2000 (Pubitemid 32044719)
31. Tanaka Y, Hongo K, Tada T, Sakai K, Kakizawa Y, Kobayashi S: Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index. J Neurosurg 98:359-365, 2003 (Pubitemid 36151032)
32. Thapar K, Kovacs K, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ, et al: Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 38:99-107, 1996 (Pubitemid 26002389)
33. Thapar K, Scheithauer BW, Kovacs K, Pernicone PJ, Laws ER Jr: p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery 38:765-771, 1996 (Pubitemid 26087884)
34. Wolfsberger S, Knosp E: Comments on the WHO 2004 classification of pituitary tumors. Acta Neuropathol 111:66-67, 2006
35. Wolfsberger S, Wunderer J, Zachenhofer I, Czech T, Böcher-Schwarz HG, Hainfellner J, et al: Expression of cell proliferation markers in pituitary adenomas - correlation and clinical relevance of MIB-1 and anti-topoisomerase- IIalpha. Acta Neurochir (Wien) 146:831-839, 2004
36. Yokoyama S, Hirano H, Moroki K, Goto M, Imamura S, Kuratsu JI: Are nonfunctioning pituitary adenomas extending into the cavernous sinus aggressive and/or invasive? Neurosurgery 49:857-863, 2001 (Pubitemid 32927957)
37. Zhang X, Horwitz GA, Heaney AP, Nakashima M, Prezant TR, Bronstein MD, et al: Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab 84:761-767, 1999 (Pubitemid 29075718)